Reminder: You are viewing our sharing site. Content may differ from our live site.
Skip to main content

# Inflammatory bowel disease (IBD) - Whole blood and components

## Essential information

Includes

  Crohn's disease, ulcerative colitis, microscopic colitis, collagenous colitis, lymphocytic colitis.

Obligatory

  Must not donate.

Discretionary

  If diagnosed with microscopic colitis, collagenous colitis, lymphocytic colitis only, accept if:

  - Asymptomatic for more than 4 months, and
  - Any deferral required for steroid or immunosuppressive therapy has passed.

## Supporting information

See if relevant
  - Autoimmune disease
  - Immunodeficiency
  - Steroid therapy
Additional information

  Crohn's disease and ulcerative colitis usually have a chronic, relapsing course and require long-term treatment. These diseases will often have systemic effects (e.g. fatigue or anaemia) and there can be association with other disorders (e.g. arthritis) which effects the donor’s general health.

  Lesions in the gastrointestinal tract of individuals with Crohn's disease and ulcerative colitis caused by the disease can increase the risk of bacteria entering the blood stream. Bacteria in donated material can multiply to dangerous levels during storage.

  Microscopic colitis and its subtypes (collagenous colitis and lymphocytic colitis) are classified as inflammatory bowel diseases. However, there is a lower likelihood of relapsing disease and longer-term complications. Individuals with microscopic colitis can donate once their symptoms have settled and they feel well. A 4-month deferral ensures the donor's recovery is maintained. Care should be taken to ensure that, as well as complete cessation of gastrointestinal symptoms, donors are not experiencing any extra-intestinal symptoms such as fatigue, arthralgia or myalgia that affect normal activities of daily living.

Regulatory information

  Part of this entry is a requirement of the Blood Safety and Quality Regulations 2005.

Reason for change:
  Link updated from 'Immunosuppression' to 'Immunodeficiency' in the 'See if Relevant' section.
Version details:

  WB-DSG Edition 203 Release 73 (07 October 2024)

BETA

This website recently launched. Help us improve it by giving your feedback (opens in new tab)